Phreesia Inc (PHR)
24.28
+0.23
(+0.96%)
USD |
NYSE |
May 17, 16:00
24.28
0.00 (0.00%)
Pre-Market: 20:00
Phreesia SG&A Expense (Quarterly): 54.69M for Jan. 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | 54.69M |
| October 31, 2023 | 56.72M |
| July 31, 2023 | 58.23M |
| April 30, 2023 | 57.29M |
| January 31, 2023 | 56.12M |
| October 31, 2022 | 56.23M |
| July 31, 2022 | 58.41M |
| April 30, 2022 | 60.89M |
| January 31, 2022 | 58.94M |
| October 31, 2021 | 50.06M |
| July 31, 2021 | 38.41M |
| April 30, 2021 | 27.68M |
| Date | Value |
|---|---|
| January 31, 2021 | 24.70M |
| October 31, 2020 | 20.85M |
| July 31, 2020 | 19.73M |
| April 30, 2020 | 18.15M |
| January 31, 2020 | 17.80M |
| October 31, 2019 | 15.53M |
| July 31, 2019 | 15.54M |
| April 30, 2019 | 13.95M |
| January 31, 2019 | 12.35M |
| October 31, 2018 | 11.74M |
| July 31, 2018 | 11.18M |
| April 30, 2018 | 11.18M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
15.53M
Minimum
Oct 2019
60.89M
Maximum
Apr 2022
40.31M
Average
50.06M
Median
Oct 2021
SG&A Expense (Quarterly) Benchmarks
| Teladoc Health Inc | 349.39M |
| American Shared Hospital Services | 1.76M |
| Novo Integrated Sciences Inc | 2.864M |
| Astrana Health Inc | 38.72M |
| Cryo-Cell International Inc | 4.340M |